GO:0099609 microtubule lateral binding

GO:0099609 microtubule lateral binding is a molecular function term in the Gene Ontology that describes the binding of a protein or other molecule to the side, or lateral surface, of a microtubule. Microtubules are dynamic cytoskeletal polymers composed of alpha- and beta-tubulin heterodimers, and their lateral surfaces serve as docking platforms for a wide range of microtubule-associated proteins (MAPs) that regulate stability, spacing, and interactions with other cellular structures. Unlike microtubule end-binding proteins that recognize plus- or minus-end conformations, lateral binding proteins contact the cylindrical wall of the microtubule, often through repeated tubulin-binding domains. This distinction is important because lateral binding underlies functions such as microtubule bundling, cargo anchoring, and the formation of specialized cytoskeletal arrays in neurons and dividing cells [1,8]. Researchers study microtubule lateral binding to understand how cells organize their cytoplasm, how neurons maintain long processes, and how mutations in tubulin or MAPs lead to disease. For example, tubulin mutations in human neurodevelopmental disorders can perturb lateral contacts with MAPs, altering microtubule stability and neuronal migration. Tau, a classical MAP, binds along the lateral surface of microtubules through its microtubule-binding repeats, and this interaction can be influenced by amyloid-beta fibril seeds, linking lateral binding to Alzheimer's disease biology. In addition, proteins involved in stress granule dynamics and autophagy, such as NS1 binding protein and poly(A)-binding protein, intersect with microtubule-dependent processes in ALS and related neurodegeneration [2,4,7]. Because microtubule lateral binding is a molecular function rather than a single pathway, it is studied using biochemical binding assays, live-cell imaging, and genetic perturbation. CRISPR-based models allow researchers to test whether specific tubulin residues or MAP domains are required for lateral binding and downstream cellular functions [1,8]. This article summarizes the definition, mechanism, key genes, disease links, and research methods for GO:0099609, with all factual claims supported by published literature.

GO:0099609 microtubule lateral binding is defined by the Gene Ontology as the binding to the side of a microtubule. In other words, it is a molecular function in which a protein or other molecule makes direct contact with the lateral wall of a microtubule polymer, rather than with its plus or minus end. This function is distinct from microtubule motor activity, which uses ATP to move along the microtubule, and from tubulin binding to free heterodimers. Lateral binding typically involves electrostatic and hydrophobic interactions with the tubulin surface and can be mediated by repeated microtubule-binding domains, as seen in tau. The term is used to annotate gene products that physically associate with the microtubule lattice and contribute to its organization or function.

Microtubule lateral binding is important because it provides the physical basis for how cells organize microtubule arrays and how MAPs regulate microtubule stability, spacing, and interactions with other organelles. Many essential cellular processes, including neuronal development, intracellular transport, and cell division, depend on proteins that bind along the microtubule lattice rather than at its ends. Disruption of lateral binding through tubulin mutations or altered MAP function can lead to neurodevelopmental disorders and neurodegeneration, making this GO term a focal point for disease research [1,8]. In addition, lateral binding proteins are often involved in stress granule dynamics and autophagy, processes that are dysregulated in ALS and related conditions [2,4,7]. Understanding GO:0099609 therefore helps researchers interpret genetic variants and design experiments that test causal roles of specific residues or domains.

The following genes encode proteins that have been implicated in microtubule lateral binding or in related microtubule-dependent processes, based on published literature.

Microtubule lateral binding is regulated at multiple levels. Post-translational modifications of tubulin, such as detyrosination and acetylation, can alter the lateral surface and affect MAP binding. Phosphorylation of MAPs, including tau, regulates their affinity for microtubules and can be influenced by amyloid-beta fibril seeds. Autophagy pathways, including TFEB-mediated lysosomal activation, can modulate the clearance of aggregation-prone proteins that interact with microtubules, as shown in motoneuron degeneration models. Additionally, stress granule dynamics regulated by NS1 binding protein and p62 ubiquitination can impact microtubule-dependent processes. The interplay between these regulatory mechanisms ensures proper cytoskeletal function and cellular homeostasis.

Tubulin mutations in human neurodevelopmental disorders can disrupt microtubule lateral binding by altering the tubulin surface that interacts with MAPs. These mutations may impair neuronal migration, differentiation, and connectivity, leading to conditions such as lissencephaly and microcephaly. Studying lateral binding in the context of these mutations helps clarify how specific tubulin residues contribute to MAP recognition and cytoskeletal stability.

Tau is a classical microtubule lateral binding protein, and its interaction with microtubules is critical for neuronal function. In Alzheimer's disease, tau becomes hyperphosphorylated and forms aggregates, reducing its lateral binding to microtubules and leading to cytoskeletal destabilization. Amyloid-beta fibril seeds can modulate the conformational dynamics of tau microtubule-binding repeats, further linking lateral binding to disease pathology.

ALS is characterized by motoneuron degeneration, and autophagy dysfunction is a key mechanism. Trehalose induces autophagy via TFEB activation in motoneuron degeneration models, which may help clear toxic protein aggregates that affect microtubule function. NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination, a process relevant to ALS pathology. Poly(A)-binding protein and ataxin-2 condensates also contribute to ALS-related mechanisms.

Although primarily a fibrotic disease, pulmonary fibrosis involves autophagy dysregulation and fibroblast-to-myofibroblast differentiation. ATF3-activated LINC00941/lncIAPF blocks autophagy depending on ELAVL1/HuR, which may indirectly affect microtubule-dependent processes. This highlights the broad relevance of microtubule lateral binding proteins in diverse pathological contexts.

In vitro microtubule co-sedimentation assays can measure the binding of purified MAPs to polymerized microtubules. Using mutant tubulin or MAP domains, researchers can quantify lateral binding affinity and identify critical residues. These assays are often combined with structural techniques such as cryo-electron microscopy to visualize the binding interface.

Fluorescently tagged MAPs and tubulin allow real-time visualization of lateral binding dynamics in living cells. Techniques such as total internal reflection fluorescence (TIRF) microscopy and spinning-disk confocal microscopy can capture the association and dissociation of MAPs on the microtubule lattice. This approach is particularly useful in neurons to study dendritic microtubule organization.

CRISPR-Cas9 knockout, point-mutation knock-in, and tagged knock-in models enable causal testing of genes encoding microtubule lateral binding proteins. For example, knocking out MAPT or introducing disease-associated tubulin mutations can reveal effects on microtubule stability and neuronal function [1,8]. These models are essential for validating findings from biochemical assays.

Affinity purification coupled with mass spectrometry can identify proteins that co-purify with microtubules or specific MAPs, revealing components of lateral binding complexes. Proximity labeling approaches such as BioID can map the interactome of MAPs in living cells, providing insights into dynamic associations.

Researchers studying microtubule lateral binding-related genes often need to determine whether a candidate gene is causally involved in cytoskeletal regulation, disease pathogenesis, or cellular homeostasis. CRISPR-based models provide a robust way to test these hypotheses by precisely manipulating the genome.

GO:0099609 microtubule lateral binding is a fundamental molecular function that governs how proteins interact with the microtubule lattice. It is essential for cytoskeletal organization, neuronal development, and cellular homeostasis, and its dysregulation is linked to neurodevelopmental disorders, Alzheimer's disease, and ALS [1,2,8]. By combining biochemical assays, live-cell imaging, and CRISPR-based genetic models, researchers can dissect the mechanisms and disease relevance of lateral binding proteins. EDITGENE provides comprehensive CRISPR services to support these investigations.